All tracking ok but i think share price has recently got ahead of itself.
NPAT $23m for half and may just be a little bit more for 2nd half. Say $25m. So $48m for year on mkt cap $827m is a PE of 17.
Rev in 2nd half looks stronger but I note in the outlook they day "The expected revenue growth in FY2019 H2 is not anticipated to result in a proportionate increase inFY2019 H2 earnings as previously advised, given that a significant portion of that revenue will befrom early stage procurement and production".
That's why I conservatively estimate 2nd H NPAT at around $25m
I like the company and its strong order book and will be back in if it goes to lower prices.
- Forums
- ASX - By Stock
- ASB
- Ann: FY2019 H1 Results Announcement
Ann: FY2019 H1 Results Announcement, page-2
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.27 |
Change
0.100(3.15%) |
Mkt cap ! $1.072B |
Open | High | Low | Value | Volume |
$3.24 | $3.27 | $3.20 | $563.0K | 173.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 6742 | $3.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.27 | 1927 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5839 | 2.140 |
2 | 8947 | 2.130 |
10 | 45269 | 2.120 |
4 | 23275 | 2.110 |
10 | 120548 | 2.100 |
Price($) | Vol. | No. |
---|---|---|
2.160 | 31553 | 7 |
2.170 | 3763 | 1 |
2.180 | 8856 | 1 |
2.200 | 5400 | 1 |
2.220 | 10035 | 1 |
Last trade - 11.00am 25/11/2024 (20 minute delay) ? |
Featured News
ASB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online